Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Market Cap	316.74B +46.3%
Revenue (ttm)	1.64T +0.2%
Net Income	29.18B -13.8%
EPS	739.89 -12.4%
Shares Out	36.66M
PE Ratio	11.68
Forward PE	n/a
Dividend	100.00 (1.27%)
Ex-Dividend Date	Mar 31, 2026

Volume	1,338,038
Average Volume	3,105,416
Open	8,200.00
Previous Close	8,640.00
Day's Range	7,010.00 - 8,390.00
52-Week Range	5,110.00 - 12,800.00
Beta	0.22
RSI	50.14
Earnings Date	Mar 18, 2026

About Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti-inflammatory agents, neuropsychiatric solvent, digestive organ agent, antibiotic, and vitamins. The company also offers supplements for low content vi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1963
• Employees: 1,021
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 009290

Financial Performance

In 2024, Kwang Dong Pharmaceutical's revenue was 1.64 trillion, an increase of 8.34% compared to the previous year's 1.51 trillion. Earnings were 40.48 billion, an increase of 9.51%.